ICD-9 Codes for Identifying Influenza Hospitalizations in Children
To the Editor: The effect of influenza on young children is substantial, but most infections are clinically unrecognized (1) . As a result, without routine laboratory confirmation of influenza infection in patients admitted to the hospital with influenzalike illness, accurate estimates of influenza-related hospitalization rates are difficult to obtain. Several statistical models have been developed to generate estimates of excess or influenza attributable hospitalizations, all of which calculate the rate of hospitalization above baseline during periods in which influenza is circulating (2) (3) (4) (5) (6) (7) (8) . However, their accuracy is limited when viruses such as respiratory syncytial virus (RSV) and parainfluenza are cocirculating with influenza.
International Classification of Diseases, 9th revision (ICD-9) diagnostic codes specific to influenza (487.0, 487.1, and 487.8) are easily retrieved from hospital discharge records. However, researchers and public health officials have rarely used them for influenza hospitalization surveillance, presumably because they lack sensitivity for identifying true influenza infections, although this assumption has never been tested.
To determine the sensitivity and positive predictive value of influenzaspecific ICD-9 admission or discharge codes (487.0, 487.1, and 487.8), we conducted a retrospective cohort study of all patients <21 years of age hospitalized at the Children's Hospital of Philadelphia with laboratory-confirmed influenza during 3 consecutive influenza seasons (July 2001 through June 2004) (9) . We compared admission and discharge ICD-9 codes with influenza laboratory results. All specimens were initially tested by rapid solid-phase immunoassay for RSV (Binax; Portland, ME, USA) and influenza (Binax). Direct fluorescent antibody testing for adenovirus, influenza A and B, parainfluenza virus types 1, 2, and 3, and RSV was performed on specimens negative by solid-phase immunoassay for RSV or influenza. Comprehensive viral culture was established for all specimens negative for respiratory viruses by direct fluorescent antibody test.
Of 715 cases of laboratory-confirmed influenza identified (Table) , 617 (86%) were identified by rapid testing and 98 (14%) by viral culture after rapid test results were negative. A total of 529 patients had influenzaspecific admission or discharge ICD-9 codes. The sensitivity of influenzaspecific ICD-9 codes was 65% (95% confidence interval [CI] 61%-68%), and the positive predictive value was 88% (95% CI 84%-90%) (Table) . Of 66 patients who had influenza-specific admission or discharge ICD-9 codes but negative influenza laboratory results, laboratory tests confirmed parainfluenza (n = 42), Haemophilus influenzae (n = 6; 1 with a positive blood culture and 5 with positive respiratory cultures), H. parainfluenzae (n = 1 wound infection), adenovirus (n = 1), and RSV (n = 2) infections. For 5 patients, influenza infection was documented in their charts, but they had either negative influenza test results or no influenza test performed. Seven patients had the expression "follow-up" written as "f/u" in the assessment section of their admission note, which may have been interpreted by medical coders as flu. We could not determine the reason for miscoding in 2 patients.
The sensitivity of influenza-specific diagnosis codes was related to the method of laboratory confirmation. Seventy-three percent (452/617) of patients (95% CI 70%-77%) who had positive rapid test results had influenza-specific admission or discharge diagnosis codes, whereas only 11% (11/98) (95% CI 6%-19%) who had positive influenza viral cultures (and negative rapid test results) had influenza-specific diagnosis codes.
Our results have a few policy implications. First, they suggest that in hospitals where routine influenza viral testing is performed, use of admission and discharge ICD-9 codes from hospital billing data for surveillance purposes will systematically underestimate actual influenza-related hospitalizations by 35%. The higher sensitivity of influenza-specific ICD-9 codes in patients with positive rapid test results compared with positive culture results suggests that unlike viral culture results, which generally are not available before discharge, rapid test results are often used to assign influenza-specific ICD-9 codes. Thus, rapid diagnostic tests that are more sensitive (e.g., PCRbased assays) may increase the sensitivity of influenza-specific ICD-9 codes in hospitals that routinely evaluate children admitted with respiratory symptoms of unclear cause. However, the imperfect specificity (94%-98%) of rapid influenza tests will produce a small but not negligible number of false-positive results. In hospitals where influenza testing is not commonly performed, the sensitivity of influenza-specific ICD-9 codes is likely to be lower.
Second, the high positive predictive value of influenza-specific ICD-9 codes observed in this study suggests that in hospitals where influenza testing is routinely performed, most patients whose hospitalization summary includes an influenza-specific ICD-9 code actually have influenza. However, misclassification of patients with parainfluenza and H. influenzae infections as patients with influenza demonstrates the potential for systematic coding errors even when influenza testing is routine.
Epidemiologists and public health officials should be aware that influenza-specific ICD-9 codes assigned in a setting of routine rapid diagnostic testing may be useful for following trends. However, these codes will substantially underestimate the actual number of influenza-related hospitalizations.
Chikungunya Virus
Strains, Reunion Island Outbreak
To the Editor: Chikungunya virus (CHIKV) is endemic in rural tropical Africa and is penetrating urban areas in Asia. CHIKV is maintained in a sylvatic cycle that involves mosquitoes of the genus Aedes, primates, and rodents. CHIKV infection induces fever, arthralgia, and maculopapular rash. Hemorrhagic complications have been reported in some outbreaks, but a more specific symptom is severe arthralgia, often persistent, which results in long-lasting disability.
After numerous cases of CHIKV infection had been reported in Comoros and Mauritius (1), an outbreak of febrile illness was reported on Reunion Island in March 2005 (2) . The incidence of the disease remained relatively low until December 2005, when it increased dramatically. The outbreak resulted in >3,500 confirmed cases and an estimated 250,000 suspected cases (2), affecting >25% of the island's inhabitants. Encephalitic forms were reported on many occasions during the active phase of the outbreak, and >200 persons died while they were infected with CHIKV. Previously unreported complications, such as mother-to-child transmission, myocarditis, hepatitis, and extensive dermal lesions were also encountered.
Many samples, collected from patients during the outbreak, were sent to our laboratory (Virology Unit, Tropical Institute of the French Armed Forces Medical Service, Marseille, France) to identify the etiologic agent. Serum samples incubated with C6/36 cells according to previously published methods (3) yielded CHIKV. This virus was also isolated from cerebrospinal fluid collected from a patient with encephalitis, from corneas collected from asymptomatic human organ donors, and from pools of mosquitoes (Aedes albopictus and Culex quinquefasciatus) collected on the island.
Five isolates were partially sequenced. The CHIKV genome was partly amplified by using the specific primer pair OP16/OP17 (4), and reverse transcription (RT)-PCR products (1,200 nucleotides long) were cloned and sequenced (GenBank accession nos.
DQ462746-DQ462750). Comparison of partial

